EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Should Military Aircrew Members be Allowed to Use Food and Drug Administration Approved Weight Loss Medications? A Review of the Literature and Recommendations

Rachel L Prokop, Benjamin F Stork, Larry C James

Military Medicine · 01.11.2025 · 190 (11-12) · e2303-e2308

DOI: 10.1093/milmed/usaf321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Military Medicine, online erschienen am 19.06.2025. Verfasst von Rachel L Prokop und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health Psychology Fellowship, Tripler Army Medical Center, Honolulu, HI 96859, United States. Hauptthemen laut MEDLINE: Military Personnel, Anti-Obesity Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Obesity has become a world-wide epidemic, affecting both children and adults. Not only has it had a global impact, but it has had concomitant deleterious effects on recruitment and retention. In 2018, the Department of Defense permitted the use of Food and Drug Administration (FDA) approved weight loss medications by service members. However, aircrew members are not authorized to access these medications because of concerns over physiologic effects and the risk of incapacitation. To date, there has been limited research on the impacts of anti-obesity medications and military members on flight status. This review examines current literature regarding FDA-approved weight loss medications and their potential benefit for the aviation community. Recommendations for future research are proposed. Materials and Methods N-of-1 case report with detailed literature review.

Results

This review examines current literature regarding FDA approved weight loss medications and the potential benefit for the aviation community.

Conclusion

Recommendations for future research are proposed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Military PersonnelAnti-Obesity AgentsHumansUnited StatesUnited States Food and Drug AdministrationWeight LossObesityAerospace Medicine

Substanzen

Anti-Obesity Agents

Autor:innen und Institutionen

  • Health Psychology Fellowship, Tripler Army Medical Center, Honolulu, HI 96859, United States.
  • Deputy Commander for Clinical Services, Raymond W. Bliss Army Health Center, Fort Huachuca, AZ 85613, United States.
  • Director of Behavioral Medicine, Tripler Army Medical Center, Honolulu, HI 96859, United States.

Zitieren

APA

Prokop, R. L., Stork, B. F., & James, L. C. (2025). Should Military Aircrew Members be Allowed to Use Food and Drug Administration Approved Weight Loss Medications? A Review of the Literature and Recommendations. Military Medicine, 190(11-12), e2303-e2308. https://doi.org/10.1093/milmed/usaf321

Vancouver

Prokop RL, Stork BF, James LC. Should Military Aircrew Members be Allowed to Use Food and Drug Administration Approved Weight Loss Medications? A Review of the Literature and Recommendations. Military Medicine. 2025;190(11-12):e2303-e2308. doi:10.1093/milmed/usaf321

BibTeX
@article{Prokop2025,
  author = {Prokop, Rachel L and Stork, Benjamin F and James, Larry C},
  title = {Should Military Aircrew Members be Allowed to Use Food and Drug Administration Approved Weight Loss Medications? A Review of the Literature and Recommendations},
  journal = {Military Medicine},
  year = {2025},
  volume = {190},
  number = {11-12},
  pages = {e2303--e2308},
  doi = {10.1093/milmed/usaf321}
}
Kostenlos starten →